SCHEMBL7476893

SCHEMBL7476893

CC(C)[C@H](COCc1ccccn1)NC(=O)C(F)(F)C(O)C(N)Cc1ccc(O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A2 P23975 1/20 0.39
ACACB O00763 1/20 0.37
REN P00797 7/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CTSS P25774 2/20 0.37
CTSK P43235 2/20 0.37
MAOB P27338 1/20 0.36
CA2 P00918 1/20 0.36
ENPP2 Q13822 1/20 0.35
LTA4H P09960 1/20 0.35
CTSV O60911 1/20 0.34
IL1RN P18510 1/20 0.34
ERAP2 Q6P179 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7420013 0.91 LTA4H (0.48) RENCYP1A2CYP2D6MAPTTSHR
SCHEMBL8945507 0.81 LTA4H (0.55) RENMAOBLTA4HIL1RNERAP2
SCHEMBL8945490 0.81 LTA4H (0.55) RENMAOBLTA4HIL1RNERAP2
SCHEMBL7425402 0.78 LTA4H (0.48) ACACBRENMAOBLTA4HIL1RN
SCHEMBL7421310 0.78 REN (0.49) RENMAOBENPP2
SCHEMBL7421085 0.78 LTA4H (0.55) RENMAOBENPP2LTA4HIL1RN
SCHEMBL8054257 0.76 CTSD (0.48) RENCA2
SCHEMBL8945580 0.73 LTA4H (0.54) RENSMN1; SMN2MAOBLTA4HIL1RN
SCHEMBL8361267 0.73 REN (0.49) RENCTSSCTSK
SCHEMBL7425885 0.72 CTSD (0.44) ACACBRENCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0707564-B1 DIFLUORO STATONE ANALOGS MERRELL PHARMA INC (US) 2000-09-20 EP disclosed
US-6114380-A ANTIVIRAL AGENT; ADMINISTERING TO TREAT HIV INFECTION; N-(4-(N-BENZYLOXYCARBONYL-L-VALYL)AMINO-2,2-DIFLUORO-1,3-DIOXO-5-(4-(2-N -MORPHOLYL)ETHYLOXY)PHENYL-PENTYL)-O-((2-PYRIDYL)METHYL)-D-VALINOL, FOR EXAMPLE MERRELL PHARMACEUTICALS INC. (US) 2000-09-05 US disclosed
WO-1995001958-A1 DIFLUORO STATONE ANALOGS MERRELL PHARMACEUTICALS INC. (US) 1995-01-19 WO disclosed